Autoantibody Signature in Cardiac Arrest. Maguy, A.; Tardif, J.; Busseuil, D.; Ribi, C.; and Li, J. Circulation, April, 2020.
Autoantibody Signature in Cardiac Arrest [link]Paper  doi  abstract   bibtex   
Background: Cardiac arrest is a tragic event that causes one death roughly every 90 seconds worldwide. Survivors generally undergo a work-up to identify the etiology of arrest. However, 5-10% of cardiac arrest remain unexplained. As cardiac arrhythmias mostly underlie cardiac arrest and increasing evidence strongly supports the involvement of autoantibodies in arrhythmogenesis, a large-panel autoantibody screening was performed in cardiac arrest patients. Methods: This is an observational, cross-sectional study of patients from the Montreal Heart Institute (MHI) hospital cohort, a single center registry of participants. A peptide microarray was designed to screen for IgG targeting epitopes from all known cardiac ion channels with extracellular domains. Plasma samples from 23 patients with unexplained cardiac arrest were compared to 22 cardiac arrest cases of ischemic origin and a group of 29 age-, sex- and BMI-matched healthy subjects. The false discovery rate (FDR), LASSO logistic regression and random forest methods were jointly carried out to find significant differential IgG responses. Results: The autoantibody against the pore domain of the L-type voltage-gated calcium channel (Ca v 1.2) was consistently identified as a biomarker of idiopathic cardiac arrest (P=0.002, FDR=0.007, classification accuracies ≥0.83). Functional studies on human induced pluripotent stem cell-derived cardiomyocytes demonstrated that the anti-Ca v 1.2 IgG purified from patients with idiopathic cardiac arrest is proarrhythmogenic by reducing the action potential duration through calcium channel inhibition. Conclusions: The present report addresses the concept of autoimmunity and cardiac arrest. Hitherto unknown autoantibodies targeting extracellular sequences of cardiac ion channels were detected. Moreover, the study identified an autoantibody signature specific to patients with cardiac arrest.
@article{maguy_autoantibody_2020,
	title = {Autoantibody {Signature} in {Cardiac} {Arrest}},
	issn = {0009-7322, 1524-4539},
	url = {https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.044408},
	doi = {10.1161/CIRCULATIONAHA.119.044408},
	abstract = {Background:
              Cardiac arrest is a tragic event that causes one death roughly every 90 seconds worldwide. Survivors generally undergo a work-up to identify the etiology of arrest. However, 5-10\% of cardiac arrest remain unexplained. As cardiac arrhythmias mostly underlie cardiac arrest and increasing evidence strongly supports the involvement of autoantibodies in arrhythmogenesis, a large-panel autoantibody screening was performed in cardiac arrest patients.
            
            
              Methods:
              This is an observational, cross-sectional study of patients from the Montreal Heart Institute (MHI) hospital cohort, a single center registry of participants. A peptide microarray was designed to screen for IgG targeting epitopes from all known cardiac ion channels with extracellular domains. Plasma samples from 23 patients with unexplained cardiac arrest were compared to 22 cardiac arrest cases of ischemic origin and a group of 29 age-, sex- and BMI-matched healthy subjects. The false discovery rate (FDR), LASSO logistic regression and random forest methods were jointly carried out to find significant differential IgG responses.
            
            
              Results:
              The autoantibody against the pore domain of the L-type voltage-gated calcium channel (Ca
              v
              1.2) was consistently identified as a biomarker of idiopathic cardiac arrest (P=0.002, FDR=0.007, classification accuracies ≥0.83). Functional studies on human induced pluripotent stem cell-derived cardiomyocytes demonstrated that the anti-Ca
              v
              1.2 IgG purified from patients with idiopathic cardiac arrest is proarrhythmogenic by reducing the action potential duration through calcium channel inhibition.
            
            
              Conclusions:
              The present report addresses the concept of autoimmunity and cardiac arrest. Hitherto unknown autoantibodies targeting extracellular sequences of cardiac ion channels were detected. Moreover, the study identified an autoantibody signature specific to patients with cardiac arrest.},
	language = {en},
	urldate = {2020-04-27},
	journal = {Circulation},
	author = {Maguy, Ange and Tardif, Jean-Claude and Busseuil, David and Ribi, Camillo and Li, Jin},
	month = apr,
	year = {2020},
	keywords = {Application - Biomarker Discovery, Application - Other Disease, Country - Canada, Country - Switzerland, Figure, Human, PEPperCHIP - Customized - Linear, PEPperMAP - Biomarker Discovery, PEPperMAP - Epitope Mapping - Linear, Sample Type - Plasma},
	pages = {CIRCULATIONAHA.119.044408},
}
Downloads: 0